Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been confirmed by biopsy to have a specific type of nasopharyngeal (throat/nose area) cancer called nonkeratinizing nasopharyngeal carcinoma (WHO types II or III).
- People who have been newly diagnosed with this cancer at stage I through IVa, based on a standard international staging system.
- People whose cancer is located on one side of the nasopharynx only and does not cross the midline, as confirmed by camera examination and MRI scan.
- People who are planned to receive a type of targeted radiation treatment called IMRT, with chemotherapy given according to standard Chinese oncology guidelines based on their cancer stage.
- People who have not received any previous cancer treatment.
- People with a Karnofsky performance score of at least 70 out of 100, which generally means they are able to carry out normal activity with some effort (confirm with trial site).
- People aged between 18 and 70 years old.
- People whose blood counts, liver function, and kidney function meet the required levels as assessed by blood tests (confirm with trial site for specific values).
- People who are willing to be informed about the research nature of the study and sign a written consent form.
Who may not be able to join:
- People whose treatment is planned with the aim of managing symptoms rather than curing the disease.
- People who have already received radiotherapy, chemotherapy, or surgery (other than diagnostic procedures) to the nasopharynx area.
- People whose cancer continued to grow or spread during initial chemotherapy before radiation treatment.
- People whose cancer has spread to distant parts of the body (metastasis).
- People whose cancer is a different type, specifically keratinized squamous cell carcinoma or basal cell-like squamous cell carcinoma.
- People who have had another cancer in the past, unless it was certain low-risk skin cancers, early-stage cervical cancer, or papillary thyroid cancer that was adequately treated.
- People with significant heart problems, including severe heart failure, unstable chest pain, a heart attack within the past year, or a serious irregular heartbeat requiring treatment.
- People who are pregnant or breastfeeding.
- People with a mental health condition, drug or alcohol dependency, or who do not have full legal capacity to make decisions for themselves.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gui-qiong Xu, Zhongshan People's Hospital, Guangdong, China
Phone: +8613528109888
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Local Relapse-free Survival(LRFS); Incidence of hearing impairment worse than graded 2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.